Abstract
Physical inactivity and sedentary behavior are associated with higher risks of age-related morbidity and mortality. However, whether they causally contribute to accelerating biological aging has not been fully elucidated. Utilizing the largest available genome-wide association study (GWAS) summary data, we implemented a comprehensive analytical framework to investigate the causal relationships between moderate-to-vigorous leisure-time physical activity (MVPA), leisure screen time (LST), and four epigenetic age acceleration (EAA) measures: HannumAgeAccel, intrinsic HorvathAgeAccel, PhenoAgeAccel, and GrimAgeAccel. Shared genetic backgrounds across these traits were quantified through genetic correlation analysis. Overall and independent causal effects were assessed through univariable and multivariable Mendelian randomization (MR). A recently developed tissue-partitioned MR approach was further adopted to explore potential tissue-specific pathway that contributes to the observed causal relationships. Among the four EAA measures investigated, consistent results were identified for PhenoAgeAccel and GrimAgeAccel. These two measures were negatively genetically correlated with MVPA (rg=−0.18∼−0.29) and positively genetically correlated with LST (rg=0.22∼0.37). Univariable MR yielded a robust effect of genetically predicted LST on GrimAgeAccel (βIVW =0.69, P=1.10×10−7), while MVPA (βIVW=−1.02, P=1.50×10−2) and LST (βIVW=0.37, P=1.90×10−2) showed marginal causal effects on PhenoAgeAccel. Multivariable MR suggested an independent causal role of LST in GrimAgeAccel after accounting for effects of MVPA and other important confounders. Tissue-partitioned MR suggested skeletal muscle tissue associated variants be predominantly responsible for driving the effect of LST on GrimAgeAccel. Findings support sedentary lifestyles as a modifiable causal risk factor in accelerating epigenetic aging, emphasizing the need for preventive strategies to reduce sedentary screen time for healthy aging.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by funds from the National Natural Science Foundation of China (82204170).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In our study, we utilized publicly available summary-level data from original studies that had received ethical approval and consent for participation. GWAS summary data are accessible in all original studies. GWAS summary data of leisure-time physical activity and sedentary behavior, https://www.ebi.ac.uk/gwas/publications/36071172, GWAS summary data of four epigenetic age acceleration measures, https://www.ebi.ac.uk/gwas/publications/34187551 or https://datashare.ed.ac.uk/handle/10283/3645, GWAS summary data of educational attainment, http://www.thessgac.org/data, GWAS summary data of smoking and drinking, https://www.ebi.ac.uk/gwas/publications/30643251, GWAS summary data of BMI, https://zenodo.org/record/1251813, GWAS summary data of sleep duration, https://www.ebi.ac.uk/gwas/publications/30846698, GWAS summary data of parents age at death, https://www.ebi.ac.uk/gwas/publications/29227965. The data of eQTL are accessible at the website of SMR (Summary Mendelian Randomization, https://cnsgenomics.com/software/smr/), which has already mapped the eQTL data to the hg19 genome build using the GRCh37 reference assembly.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes